Royal Bank of Canada’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.4M | Buy |
337,138
+194,442
| +136% | +$9.46M | ﹤0.01% | 1522 |
|
|
2025
Q1 | $4.86M | Buy |
142,696
+31,392
| +28% | +$1.07M | ﹤0.01% | 2041 |
|
|
2024
Q4 | $4.38M | Sell |
111,304
-8,867
| -7% | -$349K | ﹤0.01% | 2126 |
|
|
2024
Q3 | $5.65M | Buy |
120,171
+33,768
| +39% | +$1.59M | ﹤0.01% | 1921 |
|
|
2024
Q2 | $4.67M | Buy |
86,403
+1,628
| +2% | +$87.9K | ﹤0.01% | 2011 |
|
|
2024
Q1 | $5.78M | Sell |
84,775
-5,608
| -6% | -$382K | ﹤0.01% | 1833 |
|
|
2023
Q4 | $5.66M | Sell |
90,383
-6,552
| -7% | -$410K | ﹤0.01% | 1836 |
|
|
2023
Q3 | $4.4M | Sell |
96,935
-2,098
| -2% | -$95.2K | ﹤0.01% | 1897 |
|
|
2023
Q2 | $5.56M | Buy |
99,033
+2,791
| +3% | +$157K | ﹤0.01% | 1768 |
|
|
2023
Q1 | $4.35M | Sell |
96,242
-3,364
| -3% | -$152K | ﹤0.01% | 1938 |
|
|
2022
Q4 | $4.05M | Sell |
99,606
-34,765
| -26% | -$1.41M | ﹤0.01% | 1996 |
|
|
2022
Q3 | $8.78M | Sell |
134,371
-91,146
| -40% | -$5.96M | ﹤0.01% | 1421 |
|
|
2022
Q2 | $13.7M | Sell |
225,517
-16,466
| -7% | -$1M | ﹤0.01% | 1204 |
|
|
2022
Q1 | $15.2M | Buy |
241,983
+3,651
| +2% | +$229K | ﹤0.01% | 1252 |
|
|
2021
Q4 | $18.1M | Sell |
238,332
-1,511
| -0.6% | -$115K | ﹤0.01% | 1259 |
|
|
2021
Q3 | $26.8M | Buy |
239,843
+3,883
| +2% | +$435K | 0.01% | 1001 |
|
|
2021
Q2 | $38.2M | Buy |
235,960
+6,372
| +3% | +$1.03M | 0.01% | 816 |
|
|
2021
Q1 | $28M | Buy |
229,588
+7,475
| +3% | +$911K | 0.01% | 958 |
|
|
2020
Q4 | $34M | Buy |
222,113
+19,441
| +10% | +$2.98M | 0.01% | 787 |
|
|
2020
Q3 | $17M | Buy |
202,672
+23,730
| +13% | +$1.98M | 0.01% | 1041 |
|
|
2020
Q2 | $13.2M | Buy |
178,942
+64,285
| +56% | +$4.72M | 0.01% | 1137 |
|
|
2020
Q1 | $4.86M | Buy |
114,657
+6,420
| +6% | +$272K | ﹤0.01% | 1580 |
|
|
2019
Q4 | $6.59M | Buy |
108,237
+2,206
| +2% | +$134K | ﹤0.01% | 1641 |
|
|
2019
Q3 | $4.35M | Sell |
106,031
-14,394
| -12% | -$590K | ﹤0.01% | 1845 |
|
|
2019
Q2 | $5.67M | Buy |
120,425
+51,665
| +75% | +$2.43M | ﹤0.01% | 1674 |
|
|
2019
Q1 | $2.46M | Buy |
68,760
+8,973
| +15% | +$321K | ﹤0.01% | 2136 |
|
|
2018
Q4 | $1.71M | Sell |
59,787
-16,971
| -22% | -$485K | ﹤0.01% | 2280 |
|
|
2018
Q3 | $3.4M | Buy |
76,758
+22,866
| +42% | +$1.01M | ﹤0.01% | 2040 |
|
|
2018
Q2 | $3.17M | Buy |
53,892
+27,272
| +102% | +$1.6M | ﹤0.01% | 1975 |
|
|
2018
Q1 | $1.22M | Buy |
26,620
+12,751
| +92% | +$583K | ﹤0.01% | 2520 |
|
|
2017
Q4 | $325K | Buy |
13,869
+6,019
| +77% | +$141K | ﹤0.01% | 3437 |
|
|
2017
Q3 | $140K | Buy |
7,850
+4,525
| +136% | +$80.7K | ﹤0.01% | 4069 |
|
|
2017
Q2 | $53K | Sell |
3,325
-51
| -2% | -$813 | ﹤0.01% | 4358 |
|
|
2017
Q1 | $74K | Buy |
+3,376
| New | +$74K | ﹤0.01% | 4270 |
|